Research done at Beilinson hospital in Petah Tikva shows the COVID-19 vaccine booster shot is effective for immunocompromised people, doubling the rate of people who developed antibodies among patients who have received heart, lung or kidney transplants, the Kan public broadcaster reports.
The report says the study’s findings have been released today and will soon be published in an academic paper.
According to the report, 73% of those who previously received a kidney transplant developed antibodies and an immune reaction to the third vaccine dose, while only 35% had developed antibodies after the second shot.
Among those who received a lung transplant, 33% developed antibodies after a booster while just 18% did so after the second shot. For those who got a heart transplant, 58% had an immune reaction compared with 31% after the first two doses.
No major side effects were observed apart from pain at the place of the injection.
“We recommend that all those who have received organ transplants come and get vaccinated with the third vaccine shot, which saves lives,” says Dr. Tuvia Ben Gal, director of the hospital’s heart failure unit.
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
— Gabriella Jacobs, multimedia journalist
Support our work
Support our work
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
From the Liveblog of
Tuesday, August 10, 2021
Add ToI as a Preferred Source on Google
